US Patent Issued to TANABE PHARMA on Aug. 18 for "Agent for preventing or treating muscular disease" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,750, issued on Aug. 18, was assigned to TANABE PHARMA Corp. (Osaka, Japan).

"Agent for preventing or treating muscular disease" was invented by Kiyoshi Ishikawa (Osaka, Japan) and Shumpei Murata (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A myoregulin inhibitor such as an antisense oligonucleotide against myoregulin or an anti-myoregulin antibody is used as an active ingredient of a prophylactic or therapeutic agent for a muscle disease such as muscular dystrophy, inclusion body myositis, amyotrophic lateral sclerosis, disused muscular atrophy, and sarcopenia."

The patent was filed on July 16, 2021, under Application No. 18/005,520...